Recent changes in the etiology of hearing disorders: perinatal drug exposure

S E Gerber1, L Epstein, L S Mencher

  • 1Department of Communication Disorders, Eastern Washington University, Cheney 99004-2431, USA.

Insights

New causes of early hearing loss in children include prenatal drug exposure, such as alcohol and cocaine. This review examines the impact on children's communication skills, noting uncertainties about auditory effects and long-term outcomes.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Audiology

Background:

  • Congenital and early-onset hearing disorders are increasingly linked to prenatal exposures.
  • Substances like alcohol and cocaine are recognized as significant risk factors for fetal development.
  • Previous understanding of these disorders has not fully encompassed the impact of maternal drug use.

Purpose of the Study:

  • To review the effects of prenatal drug exposure on the communication skills of affected children.
  • To explore emerging causes of congenital and early-onset hearing impairments.
  • To identify current knowledge gaps regarding auditory and communicative outcomes.

Main Methods:

  • Literature review of studies on prenatal substance exposure and child development.
  • Analysis of research focusing on communication and auditory function in exposed children.
  • Synthesis of findings on the impact of alcohol, cocaine, and other drugs.

Main Results:

  • Prenatal exposure to substances like alcohol and cocaine is associated with developmental challenges.
  • The impact on children's communication skills is a growing area of concern.
  • Specific auditory effects and the long-term nature of communicative impairments remain under investigation.

Conclusions:

  • Prenatal drug exposure represents a significant, recognized cause of early childhood communication deficits.
  • Further research is needed to elucidate the precise auditory effects and the persistence of these communication issues.
  • Early identification and intervention strategies are crucial for children exposed to substances in utero.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...